AstraZeneca (AZN) Reports Q4 EPS of $1.30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall St rises on AI gains as oil slides, Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips below $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- AMD stock jumps as chip rally builds ahead of summit
AstraZeneca (AZN) PT Raised to $42 at Bernstein; 'Catalyst-Rich Year'
February 5, 2018 7:44 AM ESTBernstein raised its price target on AstraZeneca (NYSE: AZN) to $42.00 (from $40.00) while maintaining a Outperform rating.
Analyst Tim Anderson said both Q4 and guidance were decent and 2018 remains a catalyst-rich year.
... More